(E)-5-((4-(4-(2-cyanovinyl)-2,6-difluorophenoxy)thieno[3,2-d]pyrimidin-2-yl)amino)picolinonitrile

ID: ALA5281060

Chembl Id: CHEMBL5281060

Max Phase: Preclinical

Molecular Formula: C21H10F2N6OS

Molecular Weight: 432.42

Associated Items:

Names and Identifiers

Canonical SMILES:  N#C/C=C/c1cc(F)c(Oc2nc(Nc3ccc(C#N)nc3)nc3ccsc23)c(F)c1

Standard InChI:  InChI=1S/C21H10F2N6OS/c22-15-8-12(2-1-6-24)9-16(23)18(15)30-20-19-17(5-7-31-19)28-21(29-20)27-14-4-3-13(10-25)26-11-14/h1-5,7-9,11H,(H,27,28,29)/b2-1+

Standard InChI Key:  BGNPXGGRHSRKNJ-OWOJBTEDSA-N

Alternative Forms

  1. Parent:

    ALA5281060

    ---

Associated Targets(Human)

MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pol Human immunodeficiency virus type 1 reverse transcriptase (18245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 432.42Molecular Weight (Monoisotopic): 432.0605AlogP: 5.31#Rotatable Bonds: 5
Polar Surface Area: 107.51Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.29CX Basic pKa: 0.96CX LogP: 5.22CX LogD: 5.22
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.43Np Likeness Score: -1.43

References

1. Sun Y, Zhou Z, Feng D, Jing L, Zhao F, Wang Z, Zhang T, Lin H, Song H, De Clercq E, Pannecouque C, Zhan P, Liu X, Kang D..  (2022)  Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs.,  65  (23.0): [PMID:36411036] [10.1021/acs.jmedchem.2c00576]

Source